Lptx stock news Results

You are searching for Lptx stock news, Below listing suggest some keywords related this keyword and listing websites with same content

Find Top Domain Names With

Searches related

Top Keywords Suggestions

1 Lptx stock news

Most Searched Keywords

Domains Actived Recently

   » Txparolelaw.com (13 seconds ago)

   » Pschk.org (4 seconds ago)

   » Skymesebooks.com (6 seconds ago)

   » Keithstowingservice.com (2 seconds ago)

   » Boatsterndrivepartnow.com (2 seconds ago)

   » Kontazzz.com (7 seconds ago)

   » Wvchamber.com (3 seconds ago)

   » Aandlhome.com (5 seconds ago)

   » Drhandicap.com (2 seconds ago)

   » Ncvps.org (18 seconds ago)

Extract All Emails from Any Domain

Find All Domains on Any IP/ Domain

About 48 Websites Link


LPTX Leap Therapeutics, INC. — Stock Price And Discussion

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 26

  • NASDAQ Updated Jul 16, 2021 10:25 PM

Leap Therapeutics, Inc. (LPTX) Latest Stock News

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 35

Get the latest Leap Therapeutics, Inc. (LPTX) stock news and headlines to help you in your trading and investing decisions.

Leap Therapeutics, Inc. (LPTX) Stock Price, News, Quote

Finance.yahoo.com   DA: 17 PA: 12 MOZ Rank: 31

  • Find the latest Leap Therapeutics, Inc
  • (LPTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

LPTX Stock Forecast, Price & News (Leap Therapeutics)

Marketbeat.com   DA: 18 PA: 20 MOZ Rank: 41

  • Leap Therapeutics' stock was trading at $2.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO)
  • Since then, LPTX stock has decreased by 27.9% and is now trading at $1.45
  • View which stocks have been most impacted by COVID-19.

LPTX News Today (Leap Therapeutics) MarketBeat

Marketbeat.com   DA: 18 PA: 25 MOZ Rank: 47

Is LPTX A Good Stock To Buy Now? finance.yahoo.com - December 12 at 1:00 AM Global Vertical Leap Training Equipment Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2025

Leap Therapeutics (LPTX) Stock Price, Quote & News Stock

Stockanalysis.com   DA: 17 PA: 13 MOZ Rank: 35

  • According to 5 analysts, the average rating for LPTX stock is "Buy." The 12-month stock price forecast is 4.80, which is an increase of 242.86% from the latest price

LPTX -- Is Its Stock Price A Worthy Investment

Stocknews.com   DA: 13 PA: 12 MOZ Rank: 31

  • The ratio of debt to operating expenses for Leap Therapeutics Inc is higher than it is for about merely 4.39% of US stocks
  • With a year-over-year growth in debt of -92.07%, Leap Therapeutics Inc's debt growth rate surpasses just 1.92% of about US stocks
  • As for revenue growth, note that LPTX's revenue has grown 300% over the

Leap Therapeutics, Inc. Common Stock (LPTX) Stock Price

Nasdaq.com   DA: 14 PA: 28 MOZ Rank: 49

Leap Therapeutics, Inc. Common Stock (LPTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

LPTX: Average Analyst Price Target Is $5.1

Stocknews.com   DA: 13 PA: 25 MOZ Rank: 46

  • LPTX has a less variance in analysts' estimates than 3.88% of all US stocks
  • Leap Therapeutics Inc's upside potential (average analyst target price relative to current price) is …

LPTX News: Earnings, Analyst Moves, And More

Stocknews.com   DA: 13 PA: 17 MOZ Rank: 39

  • Latest LPTX News From Around the Web Below are the latest news stories about Leap Therapeutics Inc that investors may wish to consider to help them evaluate LPTX as an investment opportunity
  • Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

LPTX Stock LEAP THERAPEUTICS Stock Price Today Markets

Markets.businessinsider.com   DA: 27 PA: 18 MOZ Rank: 55

LPTX: Get the latest Leap Therapeutics stock price and detailed information including LPTX news, historical charts and realtime prices.

Down 19.5% In 4 Weeks, Here's Why You Should You Buy The

Markets.businessinsider.com   DA: 27 PA: 50 MOZ Rank: 88

  • (LPTX) has been beaten down lately with too much selling pressure
  • While the stock has lost 19.5% over the past four weeks, there is …

LPTX Leap Therapeutics Inc. Stock Price & News

Wsj.com   DA: 11 PA: 24 MOZ Rank: 47

  • News Leap Therapeutics Inc.LPTX
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per

Down 19.5% In 4 Weeks, Here's Why You Should You Buy The

Zacks.com   DA: 13 PA: 50 MOZ Rank: 76

  • (LPTX Quick Quote LPTX - Free Report) has been beaten down lately with too much selling pressure.While the stock has lost 19.5% over the past four weeks, there is …

Should You Buy LPTX Stock

Stockinvest.us   DA: 14 PA: 11 MOZ Rank: 39

  • Check if LPTX has a Buy or Sell Evaluation
  • LPTX Stock Price (NASDAQ), Score, Forecast, Predictions, and LEAP THERAPEUTICS INC

Leap Therapeutics Inc

Stocktitan.net   DA: 18 PA: 11 MOZ Rank: 44

  • LPTX Leap Therapeutics Inc Latest News
  • Get news for Nasdaq companies quoted on the stock market, press releases, financial disclosures and multimedia content, for investment community, individual investors and the general public.

LPTX Leap Therapeutics Inc. Profile MarketWatch

Marketwatch.com   DA: 19 PA: 37 MOZ Rank: 72

  • Real-time last sale data for U.S
  • stock quotes reflect trades reported through Nasdaq only.

LPTX Stock Price, Leap Therapeutics Stock Quotes And News

Benzinga.com   DA: 16 PA: 11 MOZ Rank: 44

Leap Therapeutics (Leap Therapeutics: LPTX) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings

Latest News LEAP THERAPEUTICS INC. Stock ( LPTX )

Stockinvest.us   DA: 14 PA: 10 MOZ Rank: 42

  • Stock News NASDAQ:LPTX Traders shouldnt Staggering on this: Ford Motor Company (NYSE:F), Leap Therapeutics, Inc
  • (NASDAQ:LPTX) 10:20pm, Sunday, 11'th Jul 2021 Stock Equity

LPTX Stock Analysis: Price, Forecast, And News

Investorsobserver.com   DA: 25 PA: 13 MOZ Rank: 57

  • What this means: InvestorsObserver gives Leap Therapeutics Inc (LPTX) an overall rank of 41, which is below average
  • Leap Therapeutics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart
  • A rank of 41 means that 59% of stocks appear more

Leap Therapeutics Inc Stock Quote: LPTX Stock News, Quotes

Research.investors.com   DA: 22 PA: 50 MOZ Rank: 92

  • (LPTX) delivered earnings and revenue surprises of -9.09% and -3.85%, respectively, for the quarter ended March 2021
  • Do the numbers hold clues to what lies ahead for the stock? Zacks Equity Research 05/14/2021 03:15 AM ET.

Down 19.5% In 4 Weeks, Here's Why You

News.yahoo.com   DA: 14 PA: 33 MOZ Rank: 68

  • (LPTX) has been beaten down lately with too much selling pressure
  • While the stock has lost 19.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.

All News For LPTX : Leap Therapeutics, Inc.

Zacks.com   DA: 13 PA: 29 MOZ Rank: 64

  • (LPTX) Reports Q4 Loss, Lags Revenue Estimates
  • by Zacks Equity Research Published on March 12,2021
  • (LPTX) delivered earnings and revenue surprises

Leap Therapeutics (NasdaqGM:LPTX)

Simplywall.st   DA: 13 PA: 50 MOZ Rank: 86

  • High Dividend: Unable to evaluate LPTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts
  • Stability and Growth of Payments Stable Dividend: Insufficient data to determine if LPTX's dividends per share have been stable in the past.

Leap Therapeutics Inc. (NASDAQ: LPTX): A Great Stock To

Stocksregister.com   DA: 18 PA: 50 MOZ Rank: 92

  • The stock is rated as a Hold by 0 analyst(s), 3 recommend it as a Buy and 2 called the LPTX stock Overweight
  • In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell
  • Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Buy.

LPTX: Leap Therapeutics Inc

Cnbc.com   DA: 12 PA: 12 MOZ Rank: 49

Get Leap Therapeutics Inc (LPTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Leap Therapeutics News

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 88

  • and WESTMINSTER, Colo., May 12, 2021 /PRNewswire/ -- Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, and Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that they have developed an image analysis RNAscope ® assay that is …

Leap Therapeutics News

Ih.advfn.com   DA: 12 PA: 50 MOZ Rank: 89

  • CAMBRIDGE, Mass., June 14, 2021 /PRNewswire/ -- Leap Therapeutics, Inc
  • (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E
  • Onsi, President and Chief Executive Officer, will present a corporate overview at the Raymond James 2021 Virtual Human Health Innovation Conference on …

Do You Know Why LPTX Stock Jumped 12% In Extended Trades

Stockstelegraph.com   DA: 19 PA: 50 MOZ Rank: 97

  • In the last five days, LPTX shares have dropped -12.50%, while they have dropped -16.95% in the last month
  • LPTX stock increased on news that the company’s CEO will present a corporate overview of the company at a virtual health conference

LPTH LightPath Technologies Inc. — Stock Price And

Stocktwits.com   DA: 14 PA: 12 MOZ Rank: 55

  • Real-time trade and investing ideas on LightPath Technologies Inc
  • LPTH from the largest community of traders and investors.

Leap Therapeutics (NasdaqGM:LPTX)

Simplywall.st   DA: 13 PA: 50 MOZ Rank: 93

  • High Dividend: Unable to evaluate LPTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts
  • Stability and Growth of Payments Stable Dividend : Insufficient data to determine if LPTX's dividends per share have been stable in the past.

Leap Therapeutics Inc (LPTX) Stock Rises 0.61% This Week

Investorsobserver.com   DA: 25 PA: 50 MOZ Rank: 19

  • Leap Therapeutics Inc stock has fallen -33.86% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives LPTX stock a score of 34 out of a possible 100.
  • That rank is primarily influenced by a long-term technical score of 2
  • LPTX's rank also includes a short-term technical score of 4.

Leap Therapeutics Inc LPTX

Money.usnews.com   DA: 16 PA: 44 MOZ Rank: 92

  • News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right

Leap Therapeutics And Flagship Biosciences Develop Image

Stocktitan.net   DA: 18 PA: 50 MOZ Rank: 17

  • Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics
  • Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein
  • DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers.

Leap Therapeutics Inc (LPTX : NASDAQ) Stock Price & News

Google.com   DA: 14 PA: 26 MOZ Rank: 74

Get the latest Leap Therapeutics Inc (LPTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Leap Therapeutics, Inc.

Thestreet.com   DA: 17 PA: 11 MOZ Rank: 63

Leap Therapeutics Announces Completion Of Enrollment For First-Line Patient Cohort In Study Of DKN-01 In Combination With Tislelizumab For The Treatment Of …

Leap Therapeutics News: LPTX Stock Takes A Massive 58%

Investorplace.com   DA: 17 PA: 50 MOZ Rank: 14

Leap Therapeutics (LPTX) news for Friday has LPTX stock soaring following a major deal with BeiGene for its DKN-01 antibody.

LPTX Stock Price And Chart — NASDAQ:LPTX — TradingView

Tradingview.com   DA: 19 PA: 21 MOZ Rank: 77

  • View live Leap Therapeutics, Inc chart to track its stock's price action
  • Find market predictions, LPTX financials and market news.

Recently Analyzed Sites

Txparolelaw.com (13 seconds ago)

Pschk.org (4 seconds ago)

Skymesebooks.com (6 seconds ago)

Keithstowingservice.com (2 seconds ago)

Kontazzz.com (7 seconds ago)

Wvchamber.com (3 seconds ago)

Aandlhome.com (5 seconds ago)

Drhandicap.com (2 seconds ago)

Ncvps.org (18 seconds ago)

Cignatureleasing.com (1 seconds ago)

Edys.com (4 seconds ago)

Iowormax.com (7 seconds ago)

Iktissadevents.com (4 seconds ago)

Lfg1314.com (19 seconds ago)

Mcpfoundationonline.org (3 seconds ago)

Mymindmentor.com (11 seconds ago)

Mchoopfest.org (5 seconds ago)